These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23392958)

  • 1. Current role of PET, CT, MR for invasive bladder cancer.
    Lawrentschuk N; Lee ST; Scott AM
    Curr Urol Rep; 2013 Apr; 14(2):84-9. PubMed ID: 23392958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative imaging for staging bladder cancer.
    McKibben MJ; Woods ME
    Curr Urol Rep; 2015 Apr; 16(4):22. PubMed ID: 25724433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorodeoxyglucose positron-emission tomography (FDG PET)/computed tomography (CT) in bladder cancer.
    Goh V; Cook G
    BJU Int; 2013 Oct; 112(6):709. PubMed ID: 24028759
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
    Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
    BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
    Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K
    Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commentary on "Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle." Mertens LS, Fioole-Bruining A, Vegt E, Vogel WV, van Rhijn BW, Horenblas S, Department of Urology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam Hospital, Amsterdam, The Netherlands.: BJU Int 2013; 112(6):72934. doi:10.1111/bju.12109. [Epub 2013 Jun 24].
    See WA
    Urol Oncol; 2014 Nov; 32(8):1350. PubMed ID: 25488385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on use of enhanced imaging to optimize lymphadenectomy in patients undergoing minimally invasive surgery for urothelial cancer of the bladder.
    Lusuardi L; Janetschek G
    Curr Urol Rep; 2013 Apr; 14(2):124-9. PubMed ID: 23341374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary bladder cancer: role of MR imaging.
    Verma S; Rajesh A; Prasad SR; Gaitonde K; Lall CG; Mouraviev V; Aeron G; Bracken RB; Sandrasegaran K
    Radiographics; 2012; 32(2):371-87. PubMed ID: 22411938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging muscle-invasive and metastatic urothelial carcinoma.
    Malayeri AA; Pattanayak P; Apolo AB
    Curr Opin Urol; 2015 Sep; 25(5):441-8. PubMed ID: 26222929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. State-of-the-art cross-sectional imaging in bladder cancer.
    Setty BN; Holalkere NS; Sahani DV; Uppot RN; Harisinghani M; Blake MA
    Curr Probl Diagn Radiol; 2007; 36(2):83-96. PubMed ID: 17331839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computed tomography or magnetic resonance imaging - our experiences in determining preoperative TNM staging of bladder cancer.
    Stojovska-Jovanovska E; Mitreska N; Stojovski M; Lazarova A; Stavridis S; Dodevski A
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2013; 34(3):63-70. PubMed ID: 24566016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study.
    Zattoni F; Incerti E; Colicchia M; Castellucci P; Panareo S; Picchio M; Fallanca F; Briganti A; Moschini M; Gallina A; Karnes JR; Lowe V; Fanti S; Schiavina R; Rambaldi I; Ficarra V; Evangelista L
    Abdom Radiol (NY); 2018 Sep; 43(9):2391-2399. PubMed ID: 29302738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot Study of [
    Eulitt PJ; Altun E; Sheikh A; Wong TZ; Woods ME; Rose TL; Wallen EM; Pruthi RS; Smith AB; Nielsen ME; Whang YE; Kim WY; Godley PA; Basch EM; David GU; Ramirez J; Deal AM; Rathmell WK; Chen RC; Bjurlin MA; Lin W; Lee JK; Milowsky MI
    Clin Genitourin Cancer; 2020 Oct; 18(5):378-386.e1. PubMed ID: 32147364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [(18)F]Fluorodeoxyglucose - positron emission tomography/computed tomography improves staging in patients with high-risk muscle-invasive bladder cancer scheduled for radical cystectomy.
    Kollberg P; Almquist H; Bläckberg M; Cronberg C; Garpered S; Gudjonsson S; Kleist J; Lyttkens K; Patschan O; Liedberg F
    Scand J Urol; 2015; 49(4):296-301. PubMed ID: 25623843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-fluorodeoxyglucose--positron emission tomography/computed tomography aids staging and predicts mortality in patients with muscle-invasive bladder cancer.
    Mertens LS; Mir MC; Scott AM; Lee ST; Fioole-Bruining A; Vegt E; Vogel WV; Manecksha R; Bolton D; Davis ID; Horenblas S; van Rhijn BW; Lawrentschuk N
    Urology; 2014 Feb; 83(2):393-8. PubMed ID: 24468513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of parietal infiltration in carcinoma of the bladder: comparison of MR imaging, CT and histology].
    Gualdi GF; Caterino M; Di Biasi C; Trasimeni G; Pingi A; Polettini E; Ceroni L; Pirolli FM; Melone A
    Radiol Med; 1988 Dec; 76(6):604-9. PubMed ID: 3212242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative sensitivity and specificity of imaging modalities in staging bladder cancer prior to radical cystectomy: a systematic review and meta-analysis.
    Crozier J; Papa N; Perera M; Ngo B; Bolton D; Sengupta S; Lawrentschuk N
    World J Urol; 2019 Apr; 37(4):667-690. PubMed ID: 30120501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [F-18]-Fluorodeoxyglucose PET and PET-CT in diagnostic imaging evaluation of locally recurrent and metastatic bladder transitional cell carcinoma.
    Jadvar H; Quan V; Henderson RW; Conti PS
    Int J Clin Oncol; 2008 Feb; 13(1):42-7. PubMed ID: 18307018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower tract neoplasm: Update of imaging evaluation.
    Hartman R; Kawashima A
    Eur J Radiol; 2017 Dec; 97():119-130. PubMed ID: 29102424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective evaluation of MRI, ¹¹C-acetate PET/CT and contrast-enhanced CT for staging of bladder cancer.
    Vargas HA; Akin O; Schöder H; Olgac S; Dalbagni G; Hricak H; Bochner BH
    Eur J Radiol; 2012 Dec; 81(12):4131-7. PubMed ID: 22858427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.